In February and June, the reporter of China Securities Journal learned from Huadong Medicine Co.Ltd(000963) that Sinclair, its wholly-owned subsidiary in the UK, acquired 100% equity of viora, an energy source medical and beauty device company.
It is reported that viora company, founded in 2005 and headquartered in New York, is an international medical beauty company focusing on medical beauty non-invasive and minimally invasive energy source equipment, with core SVC？ And PCR? And other innovative technologies, with an advanced product portfolio of laser, strong pulse light, RF, high-pressure jet, microcrystalline skin grinding and other technologies, providing high-quality, cost-effective non-invasive and minimally invasive solutions. The application scope of the products covers the fields of anti-aging, body and face shaping and so on. Viora has sales operations in more than 60 countries / regions around the world, with more than 10000 global institutional users.
The relevant person in charge of Huadong Medicine Co.Ltd(000963) said that the company has preliminarily formulated its market strategy in China according to viora’s existing products. For example, its core product reactiontm adopts viora’s multi frequency RF core? Technology, equipped with three different treatment handles, has been approved by the US FDA and obtained the registration certificate of class III medical devices from the National Drug Administration (nmpa) in 2015. After the delivery of viora’s equity, Huadong Medicine Co.Ltd(000963) plans to quickly integrate reactiontm into China’s self operated sales team and carry out market promotion.
It is reported that viora has a rich reserve of products under research, and has covered professional instruments and equipment including women’s neck, chest and private parts, which are used for shaping, tightening, lifting and rejuvenation of women’s body parts. It is expected to be listed in overseas markets after the second half of 2022.
Huadong Medicine Co.Ltd(000963) said that this transaction is another important global strategic layout in the field of medical and American energy source equipment after Sinclair wholly acquired high tech, a Spanish energy source medical and American equipment company, in February 2021. Viora’s existing technologies and products such as intense pulsed light, microcrystalline dermabrasion and high-pressure jet are effectively complementary to Sinclair EBD business product pipeline, realizing the full layout of energy source medical and American device products and basically realizing the coverage of mainstream technologies of energy source devices. After the completion of this transaction, Huadong Medicine Co.Ltd(000963) will have more than 30 products in the field of non-invasive + minimally invasive medical beauty all over the world, including 20 products listed at home and abroad and more than 10 innovative products under research. The product portfolio covers non-surgical mainstream medical beauty fields such as facial filling, catgut embedding, skin management, body shaping, hair removal and private repair, and has formed a comprehensive product cluster, The number and coverage of products rank at the forefront of the industry, and many potential products are expected to be listed and sold at home and abroad in 2022, which will bring new growth momentum to the company’s global medical and beauty business.
Lv Liang, chairman of Huadong Medicine Co.Ltd(000963) said: “Viora’s products have differentiated competitive advantages. This transaction further expands the company’s innovative product pipeline of medical beauty, which is in line with the company’s international development strategy of medical beauty and helps to continuously consolidate and enhance the company’s comprehensive competitiveness in the field of medical beauty. In the future, the company will continue to make steady progress in accordance with the established strategy of” global operation layout and double cycle operation and development “, Strengthen the international industrial expansion with Sinclair, a wholly-owned subsidiary of the UK, as the global medical beauty operation center, adhere to the diversified business models such as independent research and development, external cooperation and equity investment, successively introduce the world-class medical beauty products with high scientific and technological gold content into China, adhere to the self-supporting model, and rely on the company’s professional clinical registration and marketing promotion team, Help the rapid commercialization of international high-quality products. Gradually realize the company’s global strategic layout of medical beauty, and strive to build Sinclair into a world-class high-end innovative medical beauty enterprise. “
